Craig Hopkinson
Chief Tech/Sci/R&D Officer at ALKERMES PLC
Net worth: 3 M $ as of 2024-04-29
Craig Hopkinson active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALKERMES PLC | Chief Tech/Sci/R&D Officer | 2017-05-29 | - |
Career history of Craig Hopkinson
Former positions of Craig Hopkinson
| Companies | Position | Start | End |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Director/Board Member | 2022-11-30 | 2023-03-01 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 2017-04-30 | 2019-12-31 |
| VERTEX PHARMACEUTICALS INCORPORATED | Chief Tech/Sci/R&D Officer | 2014-06-30 | 2017-04-30 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 2012-12-31 | 2014-06-30 |
| President | 2011-09-30 | 2012-11-30 |
Training of Craig Hopkinson
| University of the Free State | Undergraduate Degree |
Statistics
International
| United States | 5 |
| Ireland | 2 |
| South Africa | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Private companies | 3 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Stock Market
- Insiders
- Craig Hopkinson
- Experience
